As representatives of Ryan White clinics participating in the federal 340B discount program, we invite you to join us for an informal dinner and to learn about RWC-340B and its…
The 340B annual recertification period for HRSA grantees will be from February 7, 2018 to March 7, 2018. Recertification must be completed through the new 340B Office of Pharmacy Affairs…
On January 24th, the New England Journal of Medicine (“NEJM”) published a study linking the 340B program to an increase in hospital-physician consolidation in the specialties of hematology-oncology and suggesting…
On January 26th, Senate Finance Committee Chairman Orrin Hatch sent a letter to the incoming Secretary of HHS, Alex Azar, asking several questions about his plans to work with HRSA…
HRSA recently added language to its written policies on covered entity audits which suggests that the agency may conduct more follow-up audits. Those follow-up audits could result in tougher sanctions,…
“Recently introduced legislation purporting to reform the 340B program is a wolf in sheep’s clothing,” said Sara J. Dingwall, Pharm.D, BCPS, AAHIVP, President of RWC-340B and Pharmacy Director of an…
The House Energy and Commerce (E&C) Committee released a report today entitled “Review of the 340B Drug Pricing Program.” The report covers a wide range of topics under the 340B…
On Thursday, December 21st, Rep. Larry Bucshon (R-IN) and Rep. Scott Peters (D-CA) introduced the 340B PAUSE Act, H.R. 4710, in the U.S. House of Representatives. The bill would “amend…
The White House Office of Management and Budget (OMB) has posted an abstract of HRSA’s new proposed rule on 340B Ceiling Price and Manufacturer Civil Monetary Penalties (CMP). The abstract…
Washington, D.C. — “For over two decades, the 340B drug pricing program has been a cornerstone of Ryan White providers’ efforts to fight the HIV/AIDS epidemic in the United States,”…